瑞戈非尼
癌症研究
黑色素瘤
医学
体内
免疫检查点
免疫系统
激酶
药理学
免疫疗法
癌症
结直肠癌
生物
免疫学
内科学
细胞生物学
生物技术
作者
Rui-Yan Wu,Pengfei Kong,Liang-Ping Xia,Yun Huang,Zhi‐Ling Li,Yun-Yun Tang,Yu-Hong Chen,Xuan Li,Ravichandran Senthilkumar,Hai‐Liang Zhang,Ting Sun,Xue-Lian Xu,Yan Yu,Jia Mai,Xiao-Dan Peng,Dong Yang,Li-Huan Zhou,Gong-Kan Feng,Rong Deng,Xiao‐Feng Zhu
标识
DOI:10.1158/1078-0432.ccr-18-2840
摘要
Our data unveiled a new mechanism of alleviating IFNγ-induced PD-L1 and IDO1 expression and provided a rationale to explore a novel combination of ICB with regorafenib clinically, especially in melanoma with RET/Src axis activation.
科研通智能强力驱动
Strongly Powered by AbleSci AI